In 1983 Congress passed the Orphan Drug Act, which gave special tax credits to pharmaceutical manufacturers that

Question:

In 1983 Congress passed the Orphan Drug Act, which gave special tax credits to pharmaceutical manufacturers that develop drugs for treating rare diseases, and delayed the date at which generic drug manufacturers can enter the market for those drugs. Why might this legislation increase aggregate surplus? Why might it lower it?
Fantastic news! We've Found the answer you've been seeking!

Step by Step Answer:

Related Book For  book-img-for-question

Microeconomics

ISBN: 978-1118572276

5th edition

Authors: David Besanko, Ronald Braeutigam

Question Posted: